Author

Weiwei Yan

Observed name: Wei-wei Yan

Institutions: Gaozhou People's Hospital, Southern Medical University

Observed institutions: Qingdao University, TCM-Intigrated Cancer Center of Southern Medical University, Gaozhou People's Hospital, Southern Medical University

ORCID: 0000-0002-4020-8872

Observed ORCID: 0000-0002-4020-8872

OpenAlex ID: A5089733837

FGFR families: biological functions and therapeutic interventions in tumors

2023 · Qing Liu, Jiyu Huang, et al. · MedComm · 89

Regulatory network and targeted interventions for CCDC family in tumor pathogenesis

2023 · Zhen Liu, Weiwei Yan, et al. · Cancer Letters · 48

MYH9: A key protein involved in tumor progression and virus-related diseases

2024 · Qing Liu, Chao Cheng, et al. · Biomedicine & Pharmacotherapy · 46

The small molecule chemical compound cinobufotalin attenuates resistance to DDP by inducing ENKUR expression to suppress MYH9-mediated c-Myc deubiquitination in lung adenocarcinoma

2022 · Jia-hao Liu, Hui-ling Yang, et al. · Acta Pharmacologica Sinica · 45

RETRACTED: ENKUR recruits FBXW7 to ubiquitinate and degrade MYH9 and further suppress MYH9‐induced deubiquitination of β‐catenin to block gastric cancer metastasis

2022 · Jiahao Liu, Zhan Liu, et al. · MedComm · 11

SIX4 Activation in Inflammatory Response Drives the Transformation of Colorectal Epithelium into Inflammation and Tumor via Feedback-Enhancing Inflammatory Signaling to Induce Tumor Stemness Signaling

2024 · Ziyan Zhang, Huang Huang, et al. · International Journal of Biological Sciences · 9

DNASE1L3 functions as a significant metastatic suppressor by attenuating MYH9/β-catenin/c-Jun/LncRNA-KDM4A-induced E-cadherin ubiquitination degradation in nasopharyngeal carcinoma

2026 · Xingyu Tao, Xiong Liu, et al. · Cellular & Molecular Biology Letters · 1

Cinobufagin and cinobufotalin from Traditional Chinese Medicine and chemical synthesis

2023 · weiyi Fang, Qing Liu, et al. · 1

Works count: 8

Citation count: 250

H-index: 6

I10-index: 5